Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols | Madrid | Healthcare | Pharmaceuticals | €5.76B | 36.8x | 0.12 | €8.46 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grifols Pref | Madrid | Healthcare | Pharmaceuticals | €5.76B | 36.8x | 0.12 | €6.34 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laborat.Rovi | Madrid | Healthcare | Pharmaceuticals | €2.61B | 19.2x | -1.16 | €51 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almirall | Madrid | Healthcare | Pharmaceuticals | €2.07B | 193.9x | 1.61 | €9.70 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.6% Upside | Upgrade to Pro+ | |
Faes Farma | Madrid | Healthcare | Pharmaceuticals | €1.32B | 11.8x | 0.57 | €4.21 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.1% Upside | Upgrade to Pro+ | |
Pharma Mar | Madrid | Healthcare | Pharmaceuticals | €1.26B | 48.5x | €71.90 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.5% Upside | Upgrade to Pro+ | ||
Clinica Baviera | Madrid | Healthcare | Healthcare Providers & Services | €561.36M | 14.3x | 1.16 | €35 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Natac Natural Ingredients | Madrid | Healthcare | Pharmaceuticals | €273.93M | -41.6x | €0.63 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Laboratorio Reig Jofre | Madrid | Healthcare | Pharmaceuticals | €231.37M | €2.89 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Atrys Health | Madrid | Healthcare | Healthcare Providers & Services | €214.85M | -6.7x | -0.23 | €2.82 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oryzon Genomics | Madrid | Healthcare | Biotechnology & Medical Research | €174.82M | -47.4x | 14.11 | €2.71 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prim | Madrid | Healthcare | Healthcare Equipment & Supplies | €169.11M | 15.5x | -1.16 | €9.94 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pangaea Oncology | Madrid | Healthcare | Biotechnology & Medical Research | €57.72M | -9.9x | 0.12 | €1.68 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Labiana Health | Madrid | Healthcare | Pharmaceuticals | €21.40M | -16.4x | -0.21 | €3.06 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.1% Downside | Upgrade to Pro+ | |
Biotechnology Assets | Madrid | Healthcare | Biotechnology & Medical Research | €20.75M | -6.2x | 0.03 | €0.31 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Substrate Artificial Inteligence | Madrid | Healthcare | Healthcare Equipment & Supplies | €12.63M | -1x | €0.10 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Euroespes S.A. | Madrid | Healthcare | Healthcare Providers & Services | €3.67M | -3.2x | €0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |